Immunic
Tracked across 3 events · 24 articles · First seen Apr 01, 2026 · Last active Aug 10, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Immunic will participate in several investor, industry, and scientific conferences in June 2026 to present its pipeline and engage with investors and partners, potentially increasing its visibility and attracting investment.
Jun 10, 2026 · 10 articles
Business
Impact: Immunic is the company announcing its participation in investor conferences, which is a standard practice to engage with investors and analysts.
Jul 09, 2026 · 8 articles
Business
Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company developing oral therapies for neurologic diseases, announced the appointment of Elena Ridloff, CFA, to its Board of Directors, effective August 6, 2026. Ridloff brings over two decades…
Impact: Immunic is the central entity, appointing a new board member to strengthen its leadership as it approaches pivotal Phase 3 data and potential commercialization.
Aug 10, 2026 · 6 articles
80
Immunic appointed Elena RidloffImmunic Appoints Elena...
ERGEN INTELLIGENCE
Track Immunic live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard